Who has invested in MedAvail?

Cigna Ventures, Pura Vida Investments, Adage Capital Management are named among the investors backing MedAvail.

MedAvail Funding: $147M Raised, Post IPO (2023)

MedAvail funding overview

MedAvail is based in Phoenix, AZ. MedAvail has raised $147M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Post IPO announced in March 2023. The round record for MedAvail runs through 2023; nothing later has been disclosed. Investors on record include Cigna Ventures, Pura Vida Investments, Adage Capital Management. 3 distinct backers are named across the disclosed rounds.

MedAvail at a glance

Total raised: $147M
Latest round: Post IPO
Latest round date: March 2023
Headquarters: Phoenix, AZ
Notable investors: Cigna Ventures, Pura Vida Investments, Adage Capital Management

Frequently asked about MedAvail funding

How much has MedAvail raised?: MedAvail has raised $147M in total disclosed funding across the rounds on record.
Who has invested in MedAvail?: Cigna Ventures, Pura Vida Investments, Adage Capital Management are named among the investors backing MedAvail.
What was the latest MedAvail funding round?: The most recent disclosed round is a Post IPO, announced in March 2023.
Where is MedAvail based?: MedAvail is based in Phoenix, AZ.
When did MedAvail last raise?: The last disclosed MedAvail round closed in March 2023 at Post IPO.

Round data for MedAvail is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Phoenix and backer lists below.

MedAvail Funding: $147M Raised, Post IPO (2023)

MedAvail funding overview

MedAvail at a glance

Frequently asked about MedAvail funding

Companies related to MedAvail (24)

Browse related funding lists (5)